open access
Option for continuation of chemotherapy until disease progression in advanced breast cancer patients
open access
Abstract
The maintenance chemotherapy in patients with advanced breast cancer is still a matter of controversy. A meta-analysis of 11 randomised trials including phenotypically and therapeutically heterogeneous groups of patients, showed that maintenance chemotherapy prolongs time to progression and survival, and does not affect (but sometimes actually improves) quality of life. However, the decision on treatment duration should take into account the type of chemotherapy, its tolerability and effect, as well as the informed preference of the patient.
Abstract
The maintenance chemotherapy in patients with advanced breast cancer is still a matter of controversy. A meta-analysis of 11 randomised trials including phenotypically and therapeutically heterogeneous groups of patients, showed that maintenance chemotherapy prolongs time to progression and survival, and does not affect (but sometimes actually improves) quality of life. However, the decision on treatment duration should take into account the type of chemotherapy, its tolerability and effect, as well as the informed preference of the patient.
About this articleTitle
Option for continuation of chemotherapy until disease progression in advanced breast cancer patients
Journal
Nowotwory. Journal of Oncology
Issue
Pages
61-63
Published online
2016-04-07
Page views
651
Article views/downloads
2240
DOI
Bibliographic record
Nowotwory. Journal of Oncology 2016;66(1):61-63.
Authors
Renata Duchnowska